var BLIP_SITE_URL = "http://blip.tv"; 
var OUTPUT_METHOD = "document_write";

if(typeof(Url) != 'function') {
	document.write('<script type="text/javascript" src="http://blip.tv/scripts/url.js"><\/script>');
}

if(typeof(PokkariPlayer) != 'function') {
	document.write('<script type="text/javascript" src="http://blip.tv/scripts/pokkariPlayer.js?ver=2009070701"><\/script>');
}

if(typeof(DetectFlashVer) != 'function') {
	document.write('<script type="text/javascript" src="http://blip.tv/scripts/AC_OETags.js"><\/script>');
}




function play_blip_movie_794300() {
	try {
		if (typeof(PokkariPlayerOptions.showPlayerOptions) == "undefined") 
			PokkariPlayerOptions.showPlayerOptions = {};

		PokkariPlayerOptions.showPlayerOptions.playerUrl = "http://a.blip.tv/scripts/flash/showplayer.swf";

		var player = PokkariPlayer.GetInstanceByMimeType("video/x-flv");
		window.player_794300 = player;

		player.setPrimaryMediaUrl("http://blip.tv/file/get/Kklee-KennKleeEditorCorporateDealmaker282.flv?source=3");
		player.setSiteUrl('http://blip.tv');
		player.setPermalinkUrl("http://blip.tv/file/view/787993?source=3&file_type=flv");
		player.setUsersId('158692');
		player.setUsersLogin('kklee');
		player.setPostsId(794300);
		player.setGuid("F118FB14-FF49-11DC-9B18-F68EC991A62E");
		player.setPlayerTarget(document.getElementById('blip_movie_content_794300'));
		
		player.setAdvertisingType("");
		
		
		player.setWidth(240);
		player.setHeight(196);
		
		
		
		player.setAutoPlay(true);
		
		
		player.setThumbnail("http://a.images.blip.tv/Kklee-KennKleeEditorCorporateDealmaker125.png");
		
		player.setPostsTitle("Ken Klee: Editor, Corporate Dealmaker");
		player.setDescription("Ken Klee, editor of The Deal\'s Corporate Dealmaker, outlines broad trends affecting the healthcare market, consolidation, the challenges surrounding the integration of IT, and restructurings within Big Pharma. For more, check out <a href=\"http://www.thedeal.com/corporatedealmaker/\" target=\"_blank\">Corporate Dealmaker</a>.");
		player.setTopics("kenn klee,corporate dealmaker,the deal,healthcare,business,strategy,restructuring,big pharma,merger and acquisition,best practices,consolidation,it,healthcare market,biotech");
		player.setContentRating("TV-UN");
		
		
	player.render();
	} catch(e) {
		// no pp
        	
	}
}


